Coronary artery bypass surgery or drug eluting stent for unprotected left main coronary artery disease.
Article
in English
| IMSEAR
| ID: sea-87799
ABSTRACT
Coronary artery bypass surgery (CABG) is the treatment of choice in unprotected left main coronary artery disease (ULMCA). However drug eluting stent (DES) implantations in ULMCA have ushered a revolution in the field of percutaneous coronary interventions (PCI) for left main coronary artery (LMCA) by reducing peri-procedural mortality and incidence of major adverse cardiac events (MACE). More randomized trials and follow-up studies are required before PCI with DES can be chosen as alternative to CABG.
Full text:
Available
Index:
IMSEAR (South-East Asia)
Main subject:
Vascular Patency
/
Humans
/
Stents
/
Coronary Artery Bypass
/
Drug Delivery Systems
/
Coronary Disease
/
Coronary Restenosis
Type of study:
Controlled clinical trial
/
Observational study
/
Prognostic study
Language:
English
Year:
2007
Type:
Article
Similar
MEDLINE
...
LILACS
LIS